Medicaid Fraud Investigation Defense for Pharmacy Owners

Investigators may compare claims with prescriptions, dispensing records, inventory, purchase invoices, reversals, and patient records.

Potential issues can include claims for medication allegedly not dispensed, repeated billing for the same prescription, unexplained differences between purchased inventory and billed quantities, or payments to patients associated with dispensing Medicaid-funded prescriptions.

New York Penal Law §177.05 requires more than an inaccurate claim. The offense requires an intent to defraud a health plan and knowing and willful use or omission of materially false information that results in a payment to which the recipient was not entitled.

Patient payments also require context. New York Social Services Law §366-d restricts certain payments connected to referrals or purchases of Medicaid-funded items or services, but statutory and regulatory exceptions may apply. The purpose, recipient, timing, and structure of a payment therefore matter.

A pharmacy may first learn of an investigation through contact from the New York Attorney General's Medicaid Fraud Control Unit, OMIG, another state agency, or Federal investigators.

A records request, subpoena, interview request, and search warrant create different obligations.

The response should identify the issuing authority, deadline, scope, custodians of responsive data, and applicable preservation requirements. Pharmacy staff should avoid deleting, altering, recreating, or backdating records after an investigation becomes known.

A matter involving parallel Federal authorities may also require a separate white collar defense analysis.

A paid Medicaid claim does not by itself establish that a drug was properly dispensed, and an inventory discrepancy does not by itself prove intentional fraud.

The records should connect the prescriber's order to the quantity purchased, the pharmacy's dispensing event, pickup or delivery, and remaining inventory.

That comparison can distinguish recordkeeping or data-entry issues from allegations that claims were submitted for medication never dispensed or that the same inventory supported repeated reimbursement.

Raw claims data can show the same prescription more than once without proving that Medicaid actually paid the pharmacy twice.

Voids, reversals, resubmissions, rejected claims, coordination-of-benefits adjustments, and final payment data should be reconciled before a duplicate-billing conclusion is reached.

Patient-payment records require the same transaction-level analysis. Bank entries, cash records, messages, and accounting data can help establish who received a payment, its stated purpose, and how it related to the Medicaid-funded transaction.

New York health care fraud offenses under Penal Law Article 177 begin with the intentional-fraud requirements in §177.05 and can increase in degree based on the amount of wrongful payment involved.

Higher-degree charges use statutory thresholds based on payments wrongfully received from a single health plan within a period of no more than one year, rather than simply the pharmacy's total revenue or the total value of every claim reviewed by investigators.

For an owner, the investigation may focus on who directed billing, who controlled accounts, whether the owner knew how claims were generated, and whether employees or an outside billing company acted independently.

Ownership alone should not substitute for proof of the mental state and participation required by the charged offense.

On October 7, 2026, the New York Attorney General announced the arrest and indictment of a Queens pharmacy owner accused of false Medicaid and ADAP billing, patient kickbacks, medication buybacks, and money laundering. The charges are allegations, and the defendant is presumed innocent unless proven guilty.

The Attorney General also announced a separate civil asset forfeiture action seeking more than $95 million. That figure represents relief sought in pending litigation, not a final damages award or forfeiture judgment.

The New York False Claims Act uses a broader knowledge standard than the criminal health care fraud statute.

Under State Finance Law §§188 and 189, "knowing" can include actual knowledge, deliberate ignorance, or reckless disregard without requiring specific intent to defraud. Mere mistake or ordinary negligence is not the same standard.

Social Services Law §145-b can create additional civil recovery issues involving false statements, concealment, or schemes used to obtain Medicaid payments.

Federal exposure may also arise depending on the claims, funding, kickback allegations, communications, and participants involved. Those issues should be evaluated separately under applicable health care fraud statutes rather than treated as automatic consequences of a New York investigation.

Under 42 CFR §455.23, a state Medicaid agency generally must suspend payments after determining that a credible allegation of fraud is under investigation unless good cause supports no suspension or only a partial suspension.

The agency may impose the suspension without notifying the provider in advance.

The State generally must send notice within five days after imposing the suspension. A qualifying written request from law enforcement can delay that notice under the time limits specified in the regulation.

The notice should identify the general basis for the suspension, indicate the claims or business units affected when applicable, and inform the provider of the opportunity to submit written evidence.

Good-cause review may include whether another remedy would adequately protect Medicaid funds, whether beneficiary access to essential services would be jeopardized, or whether a partial suspension can address the specific claims or business unit involved.

A conviction is not required before payment suspension can occur.

A restraint on bank accounts or property is not the same as a final forfeiture order.

The legal basis for the order, property covered, duration, permitted expenses, and procedure for seeking modification or release should be identified before funds or ownership arrangements are changed.

When an investigation includes alleged proceeds or money laundering, separate asset seizure and forfeiture issues may arise.

At the same time, the pharmacy may still need to address employees, vendors, patient records, licensing requirements, reimbursement issues, and contractual obligations while responding to the investigation.